Intrastriatal injections of the succinate dehydrogenase inhibitor, malonate, cause a rise in extracellular amino acids that is blocked by MK-801
Open Access
- 1 July 1995
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 684 (2) , 221-224
- https://doi.org/10.1016/0006-8993(95)00435-s
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of 3‐Nitropropionic Acid on Synaptosomal Energy and Transmitter Metabolism: Relevance to Neurodegenerative Brain DiseasesJournal of Neurochemistry, 1994
- Effect of the Non‐NMDA Receptor Antagonist GYKI 52466 on the Microdialysate and Tissue Concentrations of Amino Acids Following Transient Forebrain IschaemiaJournal of Neurochemistry, 1994
- Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acidJournal of Neuroscience, 1993
- Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor MalonateJournal of Neurochemistry, 1993
- Inhibition of Succinate Dehydrogenase by Malonic Acid Produces an “Excitotoxic” Lesion in Rat StriatumJournal of Neurochemistry, 1993
- Alternative excitotoxic hypothesesNeurology, 1992
- Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Annals of Neurology, 1992
- Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemiaJournal of Neuroscience, 1990
- Excitatory amino acids and Alzheimer's diseaseNeurobiology of Aging, 1989
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988